Brief: Combat Drugs Approves Issue Of Upto 2.1 Mln Equity Shares On Preferential Basis
04/11/2019 13:56
Nov 4 (Reuters) - Combat Drugs Ltd COMD.BO :
* APPROVED ACQUISITION OF TARGET COMPANY AND FURTHER ISSUE
OF UPTO
2.1 MILLION EQUITY SHARES ON PREFERENTIAL BASIS
* APPROVED INCREASE OF AUTHORISED CAPITAL OF COMPANY TO 105
MILLION RUPEES
Source text for Eikon: ID:nBSE5BwfMJ
Further company coverage: COMD.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Decipher Labs
See all newsBrief: Decipher Labs Considers Proposals For Expansion In Pharma, Information Technology Sectors
Brief: Combat Drugs Approves Issue Of Upto 2.1 Mln Equity Shares On Preferential Basis
Brief: Combat Drugs Appoints Sonam Jalan As CFO
Brief: Combat Drugs Says Unit ICP Solutions Signs Contract For $1.44 Mln
Brief: Combat Drugs' MD Suchit Mohan Lal Resigns